Legislation
Posted by Sheri Harris on Sunday, June 20, 2010
Under: Legislation
IN THE UNITED STATES
HOUSE BILL
BE IT ENACTED IN LEGISLATION
Act- to create such addendum of law relating to donor individuals and their families so that they are now able to become recipients of 10% of the profits received resulting from monies and cures obtained through research by either voluntary or involuntary means. When the donor organs or cells from the body become subjected to medical research and used to develop cures by experiment it should be concluded that the donor including family members are entitled to 10% of any profit gained from such laboratory research.
Waiver of rights or permission- A person is permitted to refuse any funds that may result upon the use of any organ or cells as pertaining to research and may elect to forego it. This may stem from a personal decision to donate body and or organ for research and they may also elect to forego a standard tax deduction as provided with regards to the tax incentive for donation.
Right to contact-The individual or immediate surviving family members must also be contacted and notified once it has been established that any organ or cell is being used for reserach and the individual and family have the right to know what research their organs or cells are being used for this includes hospitals, laboratories or pharmaceutical facilities involved. The outcome of such research and the financial impact upon discovery or invention that would be attributed to the donor and or family in receiving 10% of profit or proceedes must also be disclosed.
Those who are suffering from an illness or disorder deemed as terminal or living with disease or disorder that is disabling, may be the recipient of 10% from any gain in medicine by profit made resulting from the barter of organs or cells that are used to experiment and develop cures from them. An individual or family member who is unable to afford the cost of medication and treatment resulting should be eligible and be able to elect to receive a compensation of 10% to pay for their on going medical care, health insurance which can be used to pay off such debts that occur resulting from their illness.
Families of a deceased organ or cell donor of scientific research are automatically entitled to the 10% compensation from the research facilities who have profited in ways that are financial and gained by research in discovery. This legislation if enacted will aid families who have suffered financially throughout a loved ones medical crisis.
This bill shall serve to protect those patients and their families who are subjected to bodily research and will prevent abusive methods by hospitals, laboratories and pharmaceutical facilities. Once an organ or cell is used for research and provides the means for medical prosperity for the future and intentions of cure, the donor if living and family if such donor is deceased will remain to be continually compensated by 10% of all revenues received by the lab, hospital or pharmaceutical entity resulting from continuous use of organ or cells as derived from the donor for research. Such provisions can be of legacy in that evidence of family relation must be constantly updated and documented in order to be entitled and to qualify for compensation. The legacy will be refered to as the rainy day fund. In the event that a family member in future generations should require medical care and is in need of financial resources to receive the proper medications and treatment available, once documented that they are a relative of the actual donor ie. great-great grandchild; they automatically qualify for the 10% compensation.
Dated: June 19, 2010 Attest: A. Sadiq
On Behalf of Pieces
HOUSE BILL
BE IT ENACTED IN LEGISLATION
Act- to create such addendum of law relating to donor individuals and their families so that they are now able to become recipients of 10% of the profits received resulting from monies and cures obtained through research by either voluntary or involuntary means. When the donor organs or cells from the body become subjected to medical research and used to develop cures by experiment it should be concluded that the donor including family members are entitled to 10% of any profit gained from such laboratory research.
Waiver of rights or permission- A person is permitted to refuse any funds that may result upon the use of any organ or cells as pertaining to research and may elect to forego it. This may stem from a personal decision to donate body and or organ for research and they may also elect to forego a standard tax deduction as provided with regards to the tax incentive for donation.
Right to contact-The individual or immediate surviving family members must also be contacted and notified once it has been established that any organ or cell is being used for reserach and the individual and family have the right to know what research their organs or cells are being used for this includes hospitals, laboratories or pharmaceutical facilities involved. The outcome of such research and the financial impact upon discovery or invention that would be attributed to the donor and or family in receiving 10% of profit or proceedes must also be disclosed.
Those who are suffering from an illness or disorder deemed as terminal or living with disease or disorder that is disabling, may be the recipient of 10% from any gain in medicine by profit made resulting from the barter of organs or cells that are used to experiment and develop cures from them. An individual or family member who is unable to afford the cost of medication and treatment resulting should be eligible and be able to elect to receive a compensation of 10% to pay for their on going medical care, health insurance which can be used to pay off such debts that occur resulting from their illness.
Families of a deceased organ or cell donor of scientific research are automatically entitled to the 10% compensation from the research facilities who have profited in ways that are financial and gained by research in discovery. This legislation if enacted will aid families who have suffered financially throughout a loved ones medical crisis.
This bill shall serve to protect those patients and their families who are subjected to bodily research and will prevent abusive methods by hospitals, laboratories and pharmaceutical facilities. Once an organ or cell is used for research and provides the means for medical prosperity for the future and intentions of cure, the donor if living and family if such donor is deceased will remain to be continually compensated by 10% of all revenues received by the lab, hospital or pharmaceutical entity resulting from continuous use of organ or cells as derived from the donor for research. Such provisions can be of legacy in that evidence of family relation must be constantly updated and documented in order to be entitled and to qualify for compensation. The legacy will be refered to as the rainy day fund. In the event that a family member in future generations should require medical care and is in need of financial resources to receive the proper medications and treatment available, once documented that they are a relative of the actual donor ie. great-great grandchild; they automatically qualify for the 10% compensation.
Dated: June 19, 2010 Attest: A. Sadiq
On Behalf of Pieces
In : Legislation